Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank Joshi

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Diabetes Care|November 1, 2022
Comment on Lontchi-Yimagou et al. An Atypical Form of Diabetes Among Individuals With Low BMI. Diabetes Care 2022;45:1428-1437Ranjit Unnikrishnan, Ranjit Mohan Anjana, Satinath Mukhopadhyay, et al.
Diabetes, Obesity & Metabolism|August 20, 2022
Insulin degludec/insulin aspart safely improves HbA1c: A long-term real-world cohort study (IDEA)Jothydev Kesavadev, Banshi Saboo, Rajiv Kovil, et al.
The Journal of the Association of Physicians of India|July 14, 2023
Clinical Practice Guidelines for Management of Pain, Agitation, Delirium, Immobility, and Sleep Disturbance in the Intensive Care Unit: The ABCDEF BundleRakesh Bhadade, Minal Harde, Milind Nadkar, et al.
The Journal of the Association of Physicians of India|December 14, 2025
Reimagining Type 1 Diabetes Care in India: A Three-decade Reflection on Challenges, Innovations, and Opportunities since the Diabetes Control and Complications TrialBanshi Saboo, Shambo S Samajdar, Rishi Shukla, et al.
The Lancet Regional Health. Southeast Asia|July 5, 2022
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialMonika Tandon, Wen Wu, Keith Moore, et al.
Journal of Diabetes Science and Technology|May 31, 2014
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)Vikas Pai, A Paneerselvam, Satinath Mukhopadhyay, et al.
Advances in Therapy|June 7, 2025
An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to PractitionersJothydev Kesavadev, Anjana Basanth, Arun Shankar, et al.
Journal of the Indian Medical Association|October 25, 2003
Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcerShashank Joshi, Suresh Maroli, N D Moulick, et al.
Advances in Therapy|November 20, 2016
Unproven Therapies for Diabetes and Their ImplicationsJothydev Kesavadev, Banshi Saboo, Shaukat Sadikot, et al.
Expert Opinion on Pharmacotherapy|November 10, 2022
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 studyHarold E Lebovitz, Alexander Fleming, Alan D Cherrington, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Diabetes Care|November 1, 2022
Comment on Lontchi-Yimagou et al. An Atypical Form of Diabetes Among Individuals With Low BMI. Diabetes Care 2022;45:1428-1437Ranjit Unnikrishnan, Ranjit Mohan Anjana, Satinath Mukhopadhyay, et al.
Diabetes, Obesity & Metabolism|August 20, 2022
Insulin degludec/insulin aspart safely improves HbA1c: A long-term real-world cohort study (IDEA)Jothydev Kesavadev, Banshi Saboo, Rajiv Kovil, et al.
The Journal of the Association of Physicians of India|July 14, 2023
Clinical Practice Guidelines for Management of Pain, Agitation, Delirium, Immobility, and Sleep Disturbance in the Intensive Care Unit: The ABCDEF BundleRakesh Bhadade, Minal Harde, Milind Nadkar, et al.
The Journal of the Association of Physicians of India|December 14, 2025
Reimagining Type 1 Diabetes Care in India: A Three-decade Reflection on Challenges, Innovations, and Opportunities since the Diabetes Control and Complications TrialBanshi Saboo, Shambo S Samajdar, Rishi Shukla, et al.
The Lancet Regional Health. Southeast Asia|July 5, 2022
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialMonika Tandon, Wen Wu, Keith Moore, et al.
Journal of Diabetes Science and Technology|May 31, 2014
A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V)Vikas Pai, A Paneerselvam, Satinath Mukhopadhyay, et al.
Advances in Therapy|June 7, 2025
An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to PractitionersJothydev Kesavadev, Anjana Basanth, Arun Shankar, et al.
Journal of the Indian Medical Association|October 25, 2003
Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcerShashank Joshi, Suresh Maroli, N D Moulick, et al.
Advances in Therapy|November 20, 2016
Unproven Therapies for Diabetes and Their ImplicationsJothydev Kesavadev, Banshi Saboo, Shaukat Sadikot, et al.
Expert Opinion on Pharmacotherapy|November 10, 2022
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 studyHarold E Lebovitz, Alexander Fleming, Alan D Cherrington, et al.
Pageof 12